Although elevated NFE2L3 levels correlated with protective roles during breast cancer and T-cell lymphoma [18, 62], it had the opposite effect in thyroid, pancreas, hepatocellular and colorectal carcinoma [16, 17, 22, 64]. The gene discussed is NFE2L3; the disease is T-cell non-Hodgkin lymphoma.